Category: Mergers & Acquisitions
Becton Dickinson's $12.2 billion bid for device maker CareFusion clears the required waiting period under U.S. anti-trust regulations.
Johnson & Johnson wants a federal judge to make Boston Scientific cough up some $7.2 billion - 40% of Boston's market cap - over J&J's jilting by Guidant Corp.
Will the $66 billion buyout of Allergan by Actavis suck some of the juice out of Orange County, Calif., which Allergan's called home for 60 years?
Smith & Nephew deals its wound management plant in Gilberdyke, England, to DelStar Medical for an undisclosed amount.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Report: Medtronic readies $10B bond flotation for Covidien deal; Medtech mergers stayed strong in Q3; Sources: Philips attracts private equity bids for lighting unit; Medtronic, Covidien set timetable for shareholders meetings; Report: Actavis may buy Allergan for at least $60 billion
Johnson & Johnson wants more than $5 billion in damages from Boston Scientific in a lawsuit brought over its 2006 jilting by Guidant Corp.
Medtronic's strong fiscal 2nd-quarter results pushed its stock to a 52-week high today.
Shares of Medtronic (NYSE:MDT) hit a 52-week high today on the strength of its 2nd-quarter results, peaking at $72.74 apiece.
MDT shares closed at $72.47 each, for a 4.7% gain on the day.